Elzonris (tagraxofusp)

**Product type:** Human Prescription Drug

**Active ingredient:** TAGRAXOFUSP

**Strength:** 1000 ug/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Stemline Therapeutics, Inc.

**Marketing category:** BLA (BLA761116)

**Pharmacologic class:** CD123 Interaction [EPC], CD123 Interactions [MoA], Cytotoxin [EPC], Cytotoxins [CS]